CN1775941A - 一种虫草双参酒 - Google Patents
一种虫草双参酒 Download PDFInfo
- Publication number
- CN1775941A CN1775941A CN 200410073272 CN200410073272A CN1775941A CN 1775941 A CN1775941 A CN 1775941A CN 200410073272 CN200410073272 CN 200410073272 CN 200410073272 A CN200410073272 A CN 200410073272A CN 1775941 A CN1775941 A CN 1775941A
- Authority
- CN
- China
- Prior art keywords
- wine
- cordyceps sinensis
- root
- percolate
- ginsengs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001248610 Ophiocordyceps sinensis Species 0.000 title claims description 40
- 239000003814 drug Substances 0.000 claims abstract description 35
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 9
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 9
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 9
- 244000289376 Rhus trilobata Species 0.000 claims abstract description 9
- 235000016935 Rhus trilobata var. trilobata Nutrition 0.000 claims abstract description 9
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 9
- 235000005412 red sage Nutrition 0.000 claims abstract description 9
- 241000208688 Eucommia Species 0.000 claims abstract description 7
- 244000197580 Poria cocos Species 0.000 claims abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 27
- 238000001914 filtration Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 14
- 239000000796 flavoring agent Substances 0.000 claims description 14
- 235000019634 flavors Nutrition 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 238000009738 saturating Methods 0.000 claims description 9
- 229910001220 stainless steel Inorganic materials 0.000 claims description 9
- 239000010935 stainless steel Substances 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 8
- 240000000171 Crataegus monogyna Species 0.000 claims description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 8
- 240000001638 Scurrula parasitica Species 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 8
- 241000241550 Cyathula Species 0.000 claims description 6
- 244000131316 Panax pseudoginseng Species 0.000 claims description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 6
- 239000002360 explosive Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 108010011485 Aspartame Proteins 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 6
- 241000233866 Fungi Species 0.000 abstract description 3
- 240000001307 Myosotis scorpioides Species 0.000 abstract description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 3
- 241000208340 Araliaceae Species 0.000 abstract 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 2
- 235000008434 ginseng Nutrition 0.000 abstract 2
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000180649 Panax notoginseng Species 0.000 abstract 1
- 235000003143 Panax notoginseng Nutrition 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000016508 Polygonatum biflorum var. biflorum Nutrition 0.000 abstract 1
- 241000316332 Scurrula Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 36
- 230000007812 deficiency Effects 0.000 description 28
- 201000010099 disease Diseases 0.000 description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 28
- 239000008280 blood Substances 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 26
- 239000000047 product Substances 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- 230000010354 integration Effects 0.000 description 10
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000013558 reference substance Substances 0.000 description 8
- 210000001835 viscera Anatomy 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000002105 tongue Anatomy 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- LKNITMBRWDCKMG-UHFFFAOYSA-N Epimedin B Natural products COc1ccc(cc1)C2=C(OC3OC(C)C(O)C(O)C3OC4OC(CO)C(O)C4O)C(=O)c5c(O)cc(OC6OC(CO)C(O)C(O)C6O)c(CC=C(C)C)c5O2 LKNITMBRWDCKMG-UHFFFAOYSA-N 0.000 description 2
- OCZZCFAOOWZSRX-LRHLXKJSSA-N Epimedin B Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)CO2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 OCZZCFAOOWZSRX-LRHLXKJSSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009924 canning Methods 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229930183477 epimedin Natural products 0.000 description 2
- -1 filter Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- RPLMLWBOUPDPQF-GULSFEPBSA-N 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=C(CC=C(C)C)C(O)=CC(O)=C2C1=O RPLMLWBOUPDPQF-GULSFEPBSA-N 0.000 description 1
- OGYXOOJUJQIDOX-FVCAYHPDSA-N 5-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=C(CC=C(C)C)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC(O)=C2C1=O OGYXOOJUJQIDOX-FVCAYHPDSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- IYCPMVXIUPYNHI-UHFFFAOYSA-N Icariside I Natural products C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 IYCPMVXIUPYNHI-UHFFFAOYSA-N 0.000 description 1
- NGMYNFJANBHLKA-SENBMHEBSA-N Icariside II Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O)c(C/C=C(\C)/C)c3O2)cc1 NGMYNFJANBHLKA-SENBMHEBSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- DOAOYJIOTYDTNV-UHFFFAOYSA-N butan-1-ol;ethyl acetate;hydrate Chemical compound O.CCCCO.CCOC(C)=O DOAOYJIOTYDTNV-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- OGYXOOJUJQIDOX-UHFFFAOYSA-N epimedoside A Natural products OC1C(O)C(O)C(C)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=C(CC=C(C)C)C(OC3C(C(O)C(O)C(CO)O3)O)=CC(O)=C2C1=O OGYXOOJUJQIDOX-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 229930182721 icariside Natural products 0.000 description 1
- NGMYNFJANBHLKA-LVKFHIPRSA-N icariside II Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 NGMYNFJANBHLKA-LVKFHIPRSA-N 0.000 description 1
- RPLMLWBOUPDPQF-UHFFFAOYSA-N ikarisoside A Natural products OC1C(O)C(O)C(C)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=C(CC=C(C)C)C(O)=CC(O)=C2C1=O RPLMLWBOUPDPQF-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical group 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
分组 | 总例数 | 男 | 女 | 年龄(岁) | 病程(月) | 病症 | 病种 | ||||
1 | 2 | 1 | 2 | 3 | 4 | ||||||
治疗组对照组 | 210170 | 4548 | 6522 | 48.0±12.051.5±10.1 | 43.4±42.143.6±31.0 | 1638 | 9432 | 6019 | 3712 | 4718 | 6521 |
分组 | 总例数 | 显效 | 有效 | 无效 | 总有效北(%) |
治疗组对照组 | 21070 | 9221 | 9737 | 2112 | 90.082.9 |
病症 | 总例数 | 显效 | 有效 | 无效 | 总有效率(%) |
脾肾亏虚气虚血瘀 | 12090 | 5339 | 5542 | 129 | 90.090.0 |
症状 | 例数 | 治疗前积分 | 治疗后积分 | 积分改善率(%) |
腰膝酸软倦怠乏力肢体疼痛头晕耳鸣气短懒言食欲不振不耐寒热 | 1601478915811810830 | 52849228231621318769 | 12113671106725931 | 77.172.474.866.566.268.455.1 |
检测项目 | 例数 | 治疗前 | 治疗后 | P |
IgG(g/L)IgA(g/L)IGm(g/L) | 303030 | 10.64±S2.01±0.761.57±0.38 | 10.66±3.372.04±0.661.40±0.34 | P>0.05P>0.05P>0.05 |
检测项目 | 例数 | 治疗前 | 治疗后 | P |
全血高切粘度全血低切粘度血沉(mm/h)血细胞压积(%)血浆粘度 | 3131313131 | 6.80±0.9211.03±3.3219.57±12.5747.46±4.751.86±0.18 | 6.40±1.239.49±3.3319.32±10.8544.07±4.601.81±0.11 | >0.05>0.05>0.05>0.05>0.05 |
血小板聚集率(%)纤维蛋白原(%) | 3131 | 50.71±14.9247.46±4.75 | 45.43±8.3544.07±4.60 | >0.05>0.05 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100732720A CN100491515C (zh) | 2004-11-15 | 2004-11-15 | 一种虫草双参酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100732720A CN100491515C (zh) | 2004-11-15 | 2004-11-15 | 一种虫草双参酒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1775941A true CN1775941A (zh) | 2006-05-24 |
CN100491515C CN100491515C (zh) | 2009-05-27 |
Family
ID=36765662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100732720A Active CN100491515C (zh) | 2004-11-15 | 2004-11-15 | 一种虫草双参酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100491515C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100432208C (zh) * | 2006-10-08 | 2008-11-12 | 刘家友 | 一种保健药酒 |
CN101357224B (zh) * | 2008-09-09 | 2010-11-17 | 西藏剑圣生物药物制品开发有限公司 | 一种补肾养生药制剂 |
CN103468553A (zh) * | 2013-10-12 | 2013-12-25 | 泸州品创科技有限公司 | 虫草养生酒的生产方法 |
CN105462780A (zh) * | 2014-09-04 | 2016-04-06 | 颜笑天 | 一种保健药酒及其制备方法 |
-
2004
- 2004-11-15 CN CNB2004100732720A patent/CN100491515C/zh active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100432208C (zh) * | 2006-10-08 | 2008-11-12 | 刘家友 | 一种保健药酒 |
CN101357224B (zh) * | 2008-09-09 | 2010-11-17 | 西藏剑圣生物药物制品开发有限公司 | 一种补肾养生药制剂 |
CN103468553A (zh) * | 2013-10-12 | 2013-12-25 | 泸州品创科技有限公司 | 虫草养生酒的生产方法 |
CN103468553B (zh) * | 2013-10-12 | 2014-12-10 | 泸州品创科技有限公司 | 虫草养生酒的生产方法 |
CN105462780A (zh) * | 2014-09-04 | 2016-04-06 | 颜笑天 | 一种保健药酒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100491515C (zh) | 2009-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022116807A1 (zh) | 一种富含灵芝三萜的灵芝萃取油的制备方法 | |
CN101310751B (zh) | 一种具有益气养血作用的药物组合物的检测方法 | |
CN106072626B (zh) | 一种朝医复方鹿茸保健食品及其制备方法和用途 | |
AU2019202205A1 (en) | Method to Discovery of Potential Bioactive Compounds in Herbals with Regrouping after Chromatography | |
CN104017100B (zh) | 恰玛古多糖提取物及制备方法 | |
CN1923256A (zh) | 一种药物组合物及其制备方法和质量控制方法 | |
CN105030562B (zh) | 一种抗过敏复合多糖组合物及其制备方法和应用 | |
CN104840866A (zh) | 一种健脾产品及其检测方法 | |
CN1775941A (zh) | 一种虫草双参酒 | |
CN114522193B (zh) | 一种治疗甲状腺肿大的蒙药组合物、制备方法和质控方法 | |
CN100336544C (zh) | 一种具有健肤美容作用的中药组合物及其制备方法 | |
CN106389764B (zh) | 一种中药制剂及其制备与应用 | |
CN108567914A (zh) | 一种具有改善睡眠作用的中药制剂及其制备方法和应用 | |
CN107890542A (zh) | 治疗腹泻的中药组合物及其制法 | |
CN107213179A (zh) | 一种当归饮片的炮制方法及当归饮片粉 | |
CN1176697C (zh) | 抗衰老药物组合物及其制备方法 | |
CN102430001B (zh) | 防治糖尿病的复方蔷薇果黄酮制剂及其制备方法 | |
CN1923268B (zh) | 一种用于治疗鼻炎的药物组合物及其制备方法和质量控制方法 | |
CN109568406A (zh) | 一种含蜂胶提取物的治疗老年痴呆的药物组合物及其制备方法和用途 | |
CN1796533A (zh) | 一种保健酒及其制备方法 | |
CN1768790A (zh) | 治疗糖尿病及并发症的药物及其制备方法 | |
CN1751718A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN108567810A (zh) | 一种用于防治疲劳综合征等的隆力福胶囊及其制备方法 | |
CN106727805A (zh) | 一种三七花原液的制备方法 | |
CN110917312B (zh) | 治疗小儿脾肺气虚型咳嗽变异性哮喘的中成药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YU XUAN Free format text: FORMER OWNER: FENG GUIAN Effective date: 20070323 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070323 Address after: 710016, Xi'an, Xi'an Economic Development Zone Mingguang Road 41, a vegetarian Pharmaceutical Co., Ltd. Applicant after: Yu Xuan Address before: 710004, No. 203, block B, International Building, Xincheng square, Xincheng, Shaanxi, Xi'an Applicant before: Feng Guian |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180227 Address after: Department of Stomatology Fourth Hospital of Xianyang City, 2 floor, 712000 Shaanxi qindouou Weiyang road street CRFG Patentee after: Xu Shuning Address before: Xi'an Economic Development Zone Ming Guang road No. 41, Xi'an Abadan palace pharmacy Co., Ltd. Patentee before: Yu Xuan |
|
PP01 | Preservation of patent right |
Effective date of registration: 20180807 Granted publication date: 20090527 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20190207 Granted publication date: 20090527 |
|
PD01 | Discharge of preservation of patent | ||
PP01 | Preservation of patent right |
Effective date of registration: 20190507 Granted publication date: 20090527 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20191115 Granted publication date: 20090527 |
|
PD01 | Discharge of preservation of patent | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200228 Address after: 710000 No.41 Mingguang Road, Xi'an Economic and Technological Development Zone, Xi'an City, Shaanxi Province Patentee after: Gao Peng Address before: Department of Stomatology Fourth Hospital of Xianyang City, 2 floor, 712000 Shaanxi qindouou Weiyang road street CRFG Patentee before: Xu Shuning Effective date of registration: 20200228 Address after: 710000 No.41 Mingguang Road, Xi'an Economic and Technological Development Zone, Xi'an City, Shaanxi Province Co-patentee after: Chen Zhengwen Patentee after: Wang Shaotao Address before: 710000 No.41 Mingguang Road, Xi'an Economic and Technological Development Zone, Xi'an City, Shaanxi Province Patentee before: Gao Peng |